Kivipelto M - Search Results

1

Cholesterol as a risk factor for Alzheimer's disease - epidemiological evidence.

Kivipelto M, Solomon A. Kivipelto M, et al. Acta Neurol Scand Suppl. 2006;185:50-7. doi: 10.1111/j.1600-0404.2006.00685.x. Acta Neurol Scand Suppl. 2006. PMID: 16866911 Review.

2

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study.

Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Kivipelto M, et al. BMJ. 2001 Jun 16;322(7300):1447-51. doi: 10.1136/bmj.322.7300.1447. BMJ. 2001. PMID: 11408299 Free PMC article.

3

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study.

Kivipelto M, Helkala EL, Hänninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Kivipelto M, et al. Neurology. 2001 Jun 26;56(12):1683-9. doi: 10.1212/wnl.56.12.1683. Neurology. 2001. PMID: 11425934

4

Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention.

Kivipelto M, Laakso MP, Tuomilehto J, Nissinen A, Soininen H. Kivipelto M, et al. CNS Drugs. 2002;16(7):435-44. doi: 10.2165/00023210-200216070-00001. CNS Drugs. 2002. PMID: 12056919 Review.

5

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.

Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H. Kivipelto M, et al. Ann Intern Med. 2002 Aug 6;137(3):149-55. doi: 10.7326/0003-4819-137-3-200208060-00006. Ann Intern Med. 2002. PMID: 12160362

6

Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex.

Qiu C, Kivipelto M, Agüero-Torres H, Winblad B, Fratiglioni L. Qiu C, et al. Among authors: kivipelto m. J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):828-33. doi: 10.1136/jnnp.2003.021493. J Neurol Neurosurg Psychiatry. 2004. PMID: 15145993 Free PMC article.

7

Serum lipids and hippocampal volume: the link to Alzheimer's disease?

Wolf H, Hensel A, Arendt T, Kivipelto M, Winblad B, Gertz HJ. Wolf H, et al. Among authors: kivipelto m. Ann Neurol. 2004 Nov;56(5):745-8. doi: 10.1002/ana.20289. Ann Neurol. 2004. PMID: 15505826

8

Statin therapy in Alzheimer's disease.

Kivipelto M, Solomon A, Winblad B. Kivipelto M, et al. Lancet Neurol. 2005 Sep;4(9):521-2. doi: 10.1016/S1474-4422(05)70150-2. Lancet Neurol. 2005. PMID: 16109358 No abstract available.

9

Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.

Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kåreholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A. Kivipelto M, et al. Arch Neurol. 2005 Oct;62(10):1556-60. doi: 10.1001/archneur.62.10.1556. Arch Neurol. 2005. PMID: 16216938

10

Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease.

Rovio S, Kåreholt I, Helkala EL, Viitanen M, Winblad B, Tuomilehto J, Soininen H, Nissinen A, Kivipelto M. Rovio S, et al. Among authors: kivipelto m. Lancet Neurol. 2005 Nov;4(11):705-11. doi: 10.1016/S1474-4422(05)70198-8. Lancet Neurol. 2005. PMID: 16239176 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

460 results

Search Page

Filters